Clover Health Investments Corp CLOV shares are trading lower by 1% at $7.40 in Monday's pre-market session after the company reported better-than-expected first-quarter sales results.
Clover Health reported quarterly sales of $200.30 million, which beat the analyst consensus estimate of $166.23 million.
Clover Health is a healthcare technology company. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.